What we're reading, December 8, 2015: Cigna remains committed to participation in Obamacare exchanges; Puerto Rico demands the US fix healthcare funding disparities; and fewer Americans struggle to pay medical bills.
UnitedHealth Group may regret its decision to participate in the Affordable Care Act (ACA) marketplaces and be ready to jump ship in 2017, but Cigna remains committed. In an interview with Kaiser Health News, Cigna CEO David Cordani explained that the exchanges are a long-term viable market and that the company has been viewing 2014, 2015, and 2016 as Version 1.0 of the marketplace. Currently Cigna is losing money, but Cordani said that Cigna didn’t expect to make money right away.
Puerto Rico may be sending its poor and elderly to the US mainland to get care, according to Bloomberg Business. Although Puerto Ricans are US citizens, the island is a commonwealth, not a state, and as such it gets shortchanged on funding for federal programs, such as Medicaid and Medicare. However, almost 70% of Puerto Ricans get their healthcare through Medicaid, Medicare, and Medicare Advantage. Elected officials are demanding that the US fix healthcare funding disparities.
Finally, data from the CDC found that fewer Americans are struggling to pay their medical bills, and that most progress has come from low-income individuals and those with government coverage. This is the fourth year in a row that has seen improvements and the CDC credits most of the last 2 years to coverage expansion under the ACA, reported the New York Times.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More